Harmony Biosciences Provides 2022 Business Updates
Harmony Biosciences provided business updates, noting continued strong momentum for its commercial business of WAKIX.
Source: sleepreviewmag.com
Stay updated with breaking news from Pediatric Written Request. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Harmony Biosciences provided business updates, noting continued strong momentum for its commercial business of WAKIX.
21.02.2023 - WAKIX (pitolisant) Net Revenue Increased ~41% Year-over-Year to $128.3 Million for Fourth Quarter 2022; ~43% to $437.9 Million for Full Year 2022 Achieved Net Income of $181.5 Million for Full Year 2022 Average Number of Patients on WAKIX ...